Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer

NCT04922307 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT04922307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04922307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer
Lead sponsor
Vanderbilt University Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 23, 2021
Completion date
June 15, 2027
Enrollment
240 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer